Definitive Healthcare has reported preliminary financial results for Q2 FY23, with expected revenue of $61.0 million and an adjusted net income of $12.3 million to $12.4 million. The company reaffirms its full year 2023 revenue and Adjusted EBITDA guidance. However, the company's previously issued financial statements should no longer be relied upon due to a restatement of historical financial results. This is due to a review of its sales tax positions, which revealed that sales in certain states were subject to sales tax that the company had not assessed. The company expects to record an aggregate increase to previously reported general and administrative expense of between $6.8 million to $10.2 million over the periods impacted.